Featured News
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease Treatment
NewsScientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).
READ MORE
Cancer Cells Force Normal Cells to Act Like Viruses, Helping Tumors Spread
NewsResearchers reveal how cancer cells force normal cells to act like viruses – allowing tumors to grow, resist treatment, and spread.
READ MORE
Edith Heard Unanimously Selected as Next Director General of EMBL
NewsAt its 53rd meeting yesterday, EMBL Council selected Edith Heard as the organization’s fifth Director General. Heard’s mandate is scheduled to begin 1 January 2019.
READ MORELatest News
CRISPR Reveals New Targets for Promising Cancer Drugs
News Jul 20, 2017Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.
READ MORE
BioAscent Announces New CEO and Plans to Expand Discovery Services Offering
News Jul 19, 2017BioAscent Discovery Limited appoints new CEO, Paul Smith in preparation for the expansion of companies discovery services.
READ MORE
Synthetic Material to Support Stem Cells Developed
News Jul 18, 2017New substrates have been developed which can be used to raise stem cells for a wide variety of uses.
READ MORE
Bone Cancer Drug Targets Tumors, Spares Other Organs
News Jul 16, 2017A study led by The University of Texas MD Anderson Cancer Center found a drug known as bone metastasis-targeting peptidomimetic (BMTP-11) has potential as a new therapeutic strategy for this devastating illness.
READ MORE
Big-Data Analysis Points Toward New Drug Discovery Method
News Jul 16, 2017A research team has developed a computational method to systematically probe massive amounts of open-access data to discover new ways to use drugs, including some that have already been approved for other uses.
New Algorithms Help Extract 3-D Biological Structure from Limited Data
News Jul 16, 2017CAMERA researchers capitalize on their Multi-Tiered Iterative Phasing approach to determine molecular structure of proteins and viruses from X-ray free electron laser data.
READ MORE
Elsevier Launches The Hive for 2017 to Showcase Pharma and Biotech Startup Innovation
News Jul 13, 2017Application process for innovation hub now open – with a minimum of eight startups working on cutting-edge science to be selected
READ MORE
Anti-CRISPR Proteins Decrease Damaging Off-target Effects
News Jul 13, 2017Research now shows that the countermeasure viruses came up with — inhibitory proteins referred to as anti-CRISPRs — can be used to improve CRISPR-Cas9 as a gene-therapy tool, decreasing off-target gene editing that could cause unwanted side effects.
Precision NanoSystems to Host Nanomedicines Symposium
News Jul 12, 2017Precision NanoSystems holds its second annual nanomedicines symposium called Nanomedicines that will discuss the latest developments in nanomedicine research.
READ MORE
FDA Approved Cancer Drug Now Linked to Serious Cardiovascular Side Effects
News Jul 11, 2017The team, led by researcher Marcos Malumbres, has discovered how Plk1 protein not only regulates tumor growth but is an essential protein for the control of contraction of the arteries and blood pressure.
READ MORE
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018
